Follow
Eva Forssell-Aronsson
Eva Forssell-Aronsson
Dept of Radiation Physics
Verified email at radfys.gu.se
Title
Cited by
Cited by
Year
Specific growth rate versus doubling time for quantitative characterization of tumor growth rate
E Mehrara, E Forssell-Aronsson, H Ahlman, P Bernhardt
Cancer research 67 (8), 3970-3975, 2007
2382007
Tumour therapy with radionuclides: assessment of progress and problems
J Carlsson, EF Aronsson, SO Hietala, T Stigbrand, J Tennvall
Radiotherapy and Oncology 66 (2), 107-117, 2003
1512003
Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide
P Andersson, E Forssell-Aronsson, V Johanson, B Wangberg
The Journal of Nuclear Medicine 37 (12), 2002, 1996
1291996
Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours
O Nilsson, L Kölby, B Wängberg, A Wigander, H Billig, L William-Olsson, ...
British journal of cancer 77 (4), 632-637, 1998
1251998
A method to obtain the same levels of CT image noise for patients of various sizes, to minimize radiation dose
G Starck, L Lonn, A Cederblad, E Forssell-Aronsson, L Sjostrom, ...
The British journal of radiology 75 (890), 140-150, 2002
1242002
A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake
L Kölby, P Bernhardt, H Ahlman, B Wängberg, V Johanson, A Wigander, ...
The American journal of pathology 158 (2), 745-755, 2001
1192001
Low-energy electron emitters for targeted radiotherapy of small tumours
P Bernhardt, E Forssell-Aronsson, L Jacobsson, G Skarnemark
Acta Oncologica 40 (5), 602-608, 2001
1192001
Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome
M Fjälling, P Andersson, E Forssell-Aronsson, J Gretarsdottir, ...
Journal of Nuclear Medicine 37 (9), 1519-1521, 1996
1191996
(111) In-DTPA-D-Phe (1)-octreotide binding and somatostatin receptor subtypes in thyroid tumors
EB Forssell-Aronsson, O Nilsson, SA Benjegard, L Kolby
The Journal of Nuclear Medicine 41 (4), 636, 2000
1152000
Electron-and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production
H Uusijärvi, P Bernhardt, F Rösch, HR Maecke, E Forssell-Aronsson
Journal of Nuclear Medicine 47 (5), 807-814, 2006
1112006
Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters
L Kölby, P Bernhardt, AM Levin-Jakobsen, V Johanson, B Wängberg, ...
British journal of cancer 89 (7), 1383-1388, 2003
1102003
Stunning of iodide transport by 131I irradiation in cultured thyroid epithelial cells
P Postgård, J Himmelman, U Lindencrona, N Bhogal, D Wiberg, G Berg, ...
Journal of Nuclear Medicine 43 (6), 828-834, 2002
1082002
A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity
G Starck, M Ljungberg, M Nilsson, L Jönsson, S Lundberg, T Ivarsson, ...
Journal of neural transmission 115, 1051-1062, 2008
1042008
Chromogranin A as a determinant of midgut carcinoid tumour volume
L Kölby, P Bernhardt, C Swärd, V Johanson, H Ahlman, ...
Regulatory peptides 120 (1-3), 269-273, 2004
982004
Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens
P Larsson, H Engqvist, J Biermann, E Werner Rönnerman, ...
Scientific reports 10 (1), 1-12, 2020
942020
Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment
J Svensson, G Berg, B Wängberg, M Larsson, E Forssell-Aronsson, ...
European journal of nuclear medicine and molecular imaging 42, 947-955, 2015
892015
Biodistribution and dosimetry of free 211At, 125I− and 131I− in rats
J Spetz, N Rudqvist, E Forssell-Aronsson
Cancer Biotherapy and Radiopharmaceuticals 28 (9), 657-664, 2013
812013
[177Lu-DOTA0-Tyr3]-Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed …
C Swärd, P Bernhardt, H Ahlman, B Wängberg, E Forssell-Aronsson, ...
World journal of surgery 34, 1368-1372, 2010
792010
Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours
AM Jakobsen, P Andersson, G Saglik, E Andersson, L Kölby, JD Erickson, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2001
792001
Biological response to radiation therapy
I Turesson, J Carlsson, A Brahme, B Glimelius, B Zackrisson, B Stenerlöw, ...
Acta Oncologica 42 (2), 92-106, 2003
782003
The system can't perform the operation now. Try again later.
Articles 1–20